• Latest Posts

Five key trends shaping life sciences in 2023

Ensoma acquiring Twelve Bio

Blacksmith Medicines merging with Forge Therapeutics

Prenetics acquires ACT Genomics

ADVERTISEMENT

Polyplus announces completion of acquisition of Xpress Biologics to expand plasmid DNA

New company Liminatus Pharma Inc to develop three cancer treatments

Full-Life Technologies acquiring Focus-X Therapeutics

AstraZeneca splashes out up to $320M on T-cell receptor therapy company

GHO Capital and Vistria Group to acquire CDMO Alcami

Avista Capital Partners acquires Taconic Biosciences

ADVERTISEMENT